Veradermics Doses First Patient in Phase 2 Clinical Trial for VDMN for the Treatment of Common Warts
West Hartford, CT (PRWEB) March 24, 2023 -- Veradermics Inc., a clinical-stage medical dermatology company with a pipeline of first-in-class product
Source: prweb.com